Artificial Intelligence (AI) in Medical Writing: Global Market Report 2024–2029

“Forecasting Growth to $1.78 Billion by 2029 Driven by Rising Pharmaceutical Demand, AI-Powered Drafting Tools, and Digital Health Innovations”

Artificial intelligence is steadily transforming the way healthcare communicates with science. Medical writing, once dominated by long hours of manual drafting, revisions, and regulatory hurdles, is now being accelerated by advanced AI systems capable of generating, reviewing, and refining complex documents with unprecedented precision. From clinical trial protocols to patient-facing information, AI is reducing inefficiencies while raising standards of clarity and compliance.

This shift comes at a time when the demand for new therapies, faster drug approvals, and global collaboration in medical research is higher than ever. Pharmaceutical companies, biotech firms, and medical device manufacturers are under pressure to deliver reliable data and clear communication quickly—an area where AI-enhanced writing tools offer tangible benefits. These technologies are not only reshaping the workflows of regulatory affairs teams but also redefining how knowledge is captured, translated, and shared across borders.

In 2024, the global AI in medical writing market reached $0.91 billion. Over the next five years, it is expected to nearly double, reaching $1.78 billion by 2029 at a CAGR of 14.2%. North America currently leads adoption, but momentum is building worldwide as digital health infrastructure expands and trust in AI-driven solutions grows. The years ahead will test how quickly the industry can integrate these tools into critical processes, balancing innovation with the strict demands of medical accuracy and regulatory compliance.

Market Overview

The global Artificial Intelligence (AI) in Medical Writing market has rapidly emerged as a key enabler of efficiency and accuracy in healthcare communication. In 2024, the market size reached $0.91 billion and is projected to grow to $1.78 billion by 2029, reflecting a compound annual growth rate (CAGR) of 14.2%.

North America led the market in 2024, supported by advanced digital infrastructure, strong pharmaceutical activity, and early adoption of AI-based regulatory tools.

Key Market Drivers and Trends

• Growth Driver: Rising pharmaceutical demand continues to propel the use of AI-powered tools in clinical documentation, regulatory submissions, and medical communications.

• Market Trend: The adoption of AI-enhanced medical drafting tools for regulatory and clinical documents is reshaping the medical writing process.

• Headwinds: A modest reduction of 0.7% in expected CAGR reflects the impact of ongoing trade tensions, particularly U.S. tariffs on data and software technologies that restrict access to AI-assisted biomedical datasets.

What Is Artificial Intelligence in Medical Writing?

Artificial intelligence in medical writing refers to the integration of machine learning (ML), natural language processing (NLP), and generative AI into the creation of scientific and healthcare-related documents. These documents include clinical trial reports, regulatory submissions, patient information leaflets, research manuscripts, and more.

AI enables automation, accuracy, and consistency, which are increasingly critical in medical research and healthcare delivery.

Market Segmentation

By Type

• Clinical Writing – trial documentation, regulatory submissions, patient narratives, protocols, investigator brochures.

• Type Writing – automated transcription, AI-based content generation, document formatting and proofreading.

• Scientific Writing – research papers, journal manuscripts, literature reviews, grant proposals.

• Other Types – marketing content, educational brochures, website content, chatbot/virtual assistant scripts.

By Application

• Regulatory Documentation

• Automated Literature Review

• Language Translation

• Pharmacovigilance

• Content Modularization

By End Use

• Medical Devices

• Pharmaceuticals

• Biotechnology

• Other Healthcare Providers

Market Size and Growth Forecast

• 2024 Market Value: $0.91 billion

• 2025 Market Value: $1.05 billion (CAGR 14.6%)

• 2029 Market Value: $1.78 billion (CAGR 14.2%)

Growth is supported by:

• Expansion of telemedicine and digital health services.

• Rising adoption of AI-driven clinical documentation platforms.

• Advancements in NLP and ML algorithms.

• Increasing regulatory complexity requiring accurate and timely submissions.

Industry Trends

AI-Enhanced Drafting Tools

Companies are leveraging AI-powered drafting platforms to streamline medical document workflows. For example, TrialAssure LINK AI 2.0 launched in 2024, enabling pharmaceutical firms and clinical research organizations to automate regulatory and clinical documentation processes—from first drafts to final approvals.

Mergers and Acquisitions

In March 2024, Indegene Limited acquired Trilogy Writing & Consulting GmbH, strengthening its clinical and regulatory writing expertise. The move accelerates Indegene’s generative AI investments and enhances automation in regulatory submissions.

Competitive Landscape

Leading companies in the AI in medical writing space include:

• International Business Machines (IBM)

• IQVIA Holdings Inc.

• Icon PLC

• Syneos Health Pvt Ltd

• Parexel International Corporation

• Veeva Systems

• Cactus Communications

• Tata Elxsi

• Allucent Inc.

• Certara Inc.

• Indegene Limited

• MMS Holdings Inc.

• Jasper AI Inc.

• Narrativa Inc.

• DeepCura AI, and others.

Regional Outlook

• North America: Largest market in 2024, driven by regulatory intensity and strong pharmaceutical sector.

• Europe: Significant growth, led by clinical trial expansion and EU regulatory requirements.

• Asia-Pacific: Expected fastest growth due to rising pharmaceutical production and expanding digital health adoption.

• Other Regions: South America, Middle East, and Africa present emerging opportunities, particularly in cost-efficient AI adoption.

Market Definition and Value

The AI in medical writing market includes revenues from services such as:

• Automated content generation

• Proofreading and editing

• Regulatory compliance support

• Literature review

It also includes associated sales of high-performance computing systems, GPUs, and data storage devices necessary for AI-powered content platforms. Market value is measured at “factory gate” level, representing goods and services sold directly by providers.

Strategic Outlook

The next five years will see strong demand for AI-driven medical writing tools as the healthcare sector prioritizes speed, accuracy, and compliance. Companies that invest in AI-based automation, regulatory intelligence, and clinical decision support will be well-positioned for growth.

Report Highlights